2025-2026 Regular SessionIllinois Legislature

SB1553: XYLAZINE-SCHED III-PENALTIES

Legislative Summary

Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.

Demographic Impact

Overall analysis of equity impact

Neutral
Medium ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

2/4/2025
Filed with Secretary by Sen. Patrick J. Joyce
Senate
2/4/2025
First Reading
Senate
2/4/2025
Referred to Assignments
Senate
2/11/2025
Assigned to Criminal Law
Senate
2/19/2025
To Criminal Law Clear Compliance
Senate
3/21/2025
Rule 2-10 Committee Deadline Established As April 4, 2025
Senate
4/4/2025
Rule 2-10 Committee Deadline Established As April 11, 2025
Senate
4/11/2025
Rule 3-9(a) / Re-referred to Assignments
Senate

Status Information

Current Status
Introduced(2/4/2025)
Chamber
Senate
Committee
Assignments(Senate)

Sponsors

Democrat: 1

Primary Sponsor

Patrick Joyce
Patrick Joyce
Democrat

Documents

Introduced
Bill Text2/4/202593.7 KB